Rabbit anti-Human, Mouse DTL Polyclonal Antibody | anti-DTL antibody
DTL Polyclonal Antibody
ELISA: 1:5000-1:10000
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using DTL Polyclonal Antibody at dilution of 1:30(×200))
NCBI and Uniprot Product Information
Uniprot Description
RAMP: Substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control, DNA damage response and translesion DNA synthesis. The DCX(DTL) complex, also named CRL4(CDT2) complex, mediates the polyubiquitination and subsequent degradation of CDT1 and CDKN1A/p21(CIP1). CDT1 degradation in response to DNA damage is necessary to ensure proper cell cycle regulation of DNA replication. CDKN1A/p21(CIP1) degradation during S phase or following UV irradiation is essential to control replication licensing. Most substrates require their interaction with PCNA for their polyubiquitination: substrates interact with PCNA via their PIP-box, and those containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to their degradation. In undamaged proliferating cells, the DCX(DTL) complex also promotes the 'Lys-164' monoubiquitination of PCNA, thereby being involved in PCNA-dependent translesion DNA synthesis. Belongs to the WD repeat cdt2 family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Ubiquitin ligase; Adaptor/scaffold
Chromosomal Location of Human Ortholog: 1q32
Cellular Component: nucleoplasm; centrosome; nuclear membrane; intracellular membrane-bound organelle; cytoplasm; nucleolus; chromosome; nucleus
Molecular Function: protein binding; ubiquitin-protein ligase activity
Biological Process: protein monoubiquitination; ubiquitin-dependent protein catabolic process; bypass DNA synthesis; protein polyubiquitination; regulation of cell cycle; G2/M transition DNA damage checkpoint; DNA replication; response to DNA damage stimulus; response to UV